loader
Please Wait
Applying Filters...
menu
    • menu

    Setid Fc6ae30e 868b 4ac9 B69d 900922503998 Applno 202293 Form Tablet Oral Dosage 5mg - Drug Product Composition: (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol

    Menu

    (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,187Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202293 / DOSAGE - TABLET;ORAL - 5MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DAPAGLIFLOZIN PROPANEDIOL(UNII: 887K2391VH)
    (dapagliflozin - UNII:1ULL0QJ8UC)     		dapagliflozin10mg | 5mg

    Inactive Ingredients

    Ingredient Name
    E.R. Squibb & Sons, L.L.C.
    anhydrous lactose(3SY5LH9PMK)
    cellulose, microcrystalline(OP1R32D61U)
    crospovidone(68401960MK)
    magnesium stearate(70097M6I30)
    silicon dioxide(ETJ7Z6XBU4)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.